pI: 5.7078 |
Length (AA): 817 |
MW (Da): 91525 |
Paralog Number:
18
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_126657)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G15740 | leucine-rich repeat-containing protein |
Brugia malayi | Bm1_13125 | ras-binding protein SUR-8 |
Caenorhabditis elegans | CELE_AC7.2 | Protein SOC-2, isoform B |
Dictyostelium discoideum | DDB_G0294094 | leucine-rich repeat-containing protein |
Drosophila melanogaster | Dmel_CG5407 | CG5407 gene product from transcript CG5407-RA |
Echinococcus granulosus | EgrG_000143400 | leucine rich repeat and death domain containing protein |
Echinococcus granulosus | EgrG_000729500 | leucine rich repeat protein soc 2 |
Entamoeba histolytica | EHI_167290 | leucine rich repeat / protein phosphatase 2C domain containing protein |
Entamoeba histolytica | EHI_024640 | leucine-rich repeat containing protein |
Entamoeba histolytica | EHI_081720 | leucine rich repeat / protein phosphatase 2C domain containing protein |
Entamoeba histolytica | EHI_066620 | leucine rich repeat protein, BspA family |
Entamoeba histolytica | EHI_076850 | leucine-rich repeat containing protein |
Entamoeba histolytica | EHI_050750 | leucine rich repeat / protein phosphatase 2C domain containing protein |
Entamoeba histolytica | EHI_042230 | leucine rich repeat / protein phosphatase 2C domain containing protein |
Echinococcus multilocularis | EmuJ_000141100 | leucine rich repeat and death domain containing protein |
Echinococcus multilocularis | EmuJ_000143400 | leucine rich repeat and death domain containing protein |
Echinococcus multilocularis | EmuJ_000038300 | leucine rich repeat protein SHOC 2 |
Echinococcus multilocularis | EmuJ_000729500 | leucine rich repeat protein soc 2 |
Homo sapiens | ENSG00000108061 | soc-2 suppressor of clear homolog (C. elegans) |
Homo sapiens | ENSG00000240720 | leucine-rich repeats and death domain containing 1 |
Leishmania braziliensis | LbrM.03.0030 | hypothetical protein |
Leishmania major | LmjF.03.0010 | hypothetical protein |
Loa Loa (eye worm) | LOAG_09352 | Ras-binding protein SUR-8 |
Loa Loa (eye worm) | LOAG_12528 | sur-8-PB |
Mus musculus | ENSMUSG00000024976 | soc-2 (suppressor of clear) homolog (C. elegans) |
Mus musculus | ENSMUSG00000040367 | leucine rich repeats and death domain containing 1 |
Oryza sativa | 4350068 | Os11g0213800 |
Oryza sativa | 4346736 | Os09g0325700 |
Oryza sativa | 9267951 | Os05g0297500 |
Oryza sativa | 4350057 | Os11g0211300 |
Oryza sativa | 4329969 | Os02g0613200 |
Oryza sativa | 4350060 | Os11g0212000 |
Oryza sativa | 4336323 | Os04g0503500 |
Oryza sativa | 4325115 | Os01g0260500 |
Oryza sativa | 4329870 | Os02g0597300 |
Oryza sativa | 4350067 | Os11g0213700 |
Oryza sativa | 9267061 | Os08g0265300 |
Schistosoma japonicum | Sjp_0111120 | Leucine-rich repeat protein SHOC-2, putative |
Schistosoma japonicum | Sjp_0058620 | Leucine-rich repeat and death domain-containing protein LOC401387 homolog, putative |
Schistosoma japonicum | Sjp_0305880 | Leucine-rich repeat protein SHOC-2, putative |
Schistosoma mansoni | Smp_129120 | shoc2 |
Schistosoma mansoni | Smp_108780 | hypothetical protein |
Schistosoma mansoni | Smp_008450 | hypothetical protein |
Schmidtea mediterranea | mk4.000612.04 | |
Schmidtea mediterranea | mk4.007365.00 | |
Schmidtea mediterranea | mk4.003274.00 | |
Schmidtea mediterranea | mk4.000109.02 | Leucine-rich repeat protein soc-2 |
Schmidtea mediterranea | mk4.000109.01 | |
Schmidtea mediterranea | mk4.015576.00 | |
Schmidtea mediterranea | mk4.005922.00 | Putative shoc2 |
Schmidtea mediterranea | mk4.020734.00 | |
Schmidtea mediterranea | mk4.003196.01 | |
Schmidtea mediterranea | mk4.000550.08 | |
Trypanosoma brucei gambiense | Tbg972.11.1610 | T. brucei spp.-specific protein,hypothetical protein, conserved,leucine-rich repeat protein (LRRP),leucine-rich repeat protein ( |
Trypanosoma brucei gambiense | Tbg972.3.1250 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb927.3.1490 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb11.v5.0448 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb11.v5.0838 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb927.2.950 | paraflagellar rod component, putative |
Trypanosoma brucei | Tb927.6.130 | hypothetical leucine-rich repeat protein 1 (LRRP1) |
Trypanosoma brucei | Tb927.1.480 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb11.v5.0703 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb927.1.370 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb11.v5.0602 | leucine-rich repeat protein 1 (LRRP1), putative |
Trypanosoma brucei | Tb927.1.290 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb11.v5.0560 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb927.11.1510 | leucine rich repeat protein, putative |
Trypanosoma brucei | Tb11.v5.0551 | leucine-rich repeat protein (LRRP), putative |
Trypanosoma brucei | Tb927.2.170 | leucine-rich repeat protein 1 (LRRP1), putative |
Trichomonas vaginalis | TVAG_480940 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_RG_DS113350_7 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_129560 | leucine-rich transmembrane proteins, putative |
Trichomonas vaginalis | TVAG_148510 | protein phosphatase 2C-2, putative |
Trichomonas vaginalis | TVAG_489945 | leucine-rich repeat protein, BspA family |
Trichomonas vaginalis | TVAG_334930 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_257810 | leucine-rich repeat protein, BspA family |
Trichomonas vaginalis | TVAG_171040 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_093780 | leucine-rich repeat-containing protein, putative |
Trichomonas vaginalis | TVAG_028660 | leucine-rich repeat-containing protein, putative |
Trichomonas vaginalis | TVAG_321810 | leucine-rich repeat containing protein, putative |
Trichomonas vaginalis | TVAG_093970 | leucine-rich repeat containing protein, putative |
Trichomonas vaginalis | TVAG_319030 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_210020 | podocan, putative |
Trichomonas vaginalis | TVAG_416550 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_312980 | leucine-rich repeat containing protein, putative |
Trichomonas vaginalis | TVAG_288800 | leucine-rich repeat-containing protein, putative |
Trichomonas vaginalis | TVAG_168890 | protein phosphatase 2C, putative |
Trichomonas vaginalis | TVAG_358120 | protein phosphatase 2C, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1490 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1490 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1490 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.1490 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.2.170 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.170 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.170 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.170 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.2.950 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.950 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.950 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.2.950 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.1.480 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.480 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.480 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.480 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.2.690 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.690 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.690 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.690 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.1.290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.290 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.1.370 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.370 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.370 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.370 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_AC7.2 | Caenorhabditis elegans | larval lethal | wormbase |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.